Vitaxin

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Template:Drugbox

Vitaxin (MEDI-523) is a humanized monoclonal antibody against the vascular integrin alpha-v beta-3.[1] It is shown to be a promising angiogenesis inhibitor used in the treatment of some forms of cancer. Vitaxin was in 2002 being studied for rheumatoid arthritis.[2] It is the developmental precursor of Etaracizumab (MEDI-522). Both are derived from the mouse antibody LM609.[3]

Vitaxin is safe for humans. It has little effect on advanced cancer.[3]

References

<templatestyles src="Reflist/styles.css" />

  1. ↑ Script error: No such module "Citation/CS1".
  2. ↑ Script error: No such module "Citation/CS1".
  3. ↑ a b Script error: No such module "Citation/CS1".

Script error: No such module "Check for unknown parameters".

Template:Antineoplastic-drug-stub

Retrieved from "http://debianws.lexgopc.com/wiki143/index.php?title=Vitaxin&oldid=7316886"